Clinical research of retinal laser photocoagulation and Ranibizumab on the treatment of neovascular glaucoma

International Eye Science

Volumn 15, Issue 10, 2015, Pages 1763-1765

  Jiang, Wei Peng ^a   Lu, Shan Shan ^a   Jin, Yi ^a  

^a TAIZHOU FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Neovascular glaucoma; Optical coherence tomography; Ranibizumab; Retinal laser photocoagulation

Indexed keywords

RANIBIZUMAB;

ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; EYE FUNDUS; HUMAN; INTRAOCULAR PRESSURE; IRIS DISEASE; IRIS NEOVASCULARIZATION; LASER COAGULATION; MAJOR CLINICAL STUDY; NEOVASCULAR GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; RETINAL THICKNESS; VISUAL ACUITY; VISUAL FIELD DEFECT;

EID: 84945379301     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: 10.3980/j.issn.1672-5123.2015.10.23     Document Type: Article

References (2)

1. Ryoo NK, Lee EJ, Kim TW. Regression of iris neovascularization after subconjunctival injection of bevacizumab. Korean J Ophthalmol 2013; 27(4): 299-303
2. Kabesha TB, Glacet-Bernard A, Rostaqui O, et al. Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion. J Fr Ophtalmol 2015; 38(5): 414-420